Gaush Meditech FY26 H1 net profit drops 57.9% to RMB 15.1 million; revenue falls 8.9% to RMB 595.1 millionPUBT·Aug 28, 2026 at 09:58 AM02407-0.72%
Gaush Meditech updates articles to reflect Cayman share registrar name changePUBT·Aug 17, 2026 at 11:53 AM02407-0.72%
Gaush Meditech expects H1 revenue RMB 583.2 million-RMB 607 million, down 7.1%-10.7%PUBT·Aug 3, 2026 at 10:35 AM02407-0.72%
GAUSH MEDITECH's corneal confocal microscope has obtained CE certificationAASTOCKS·Apr 12, 2026 at 06:16 AM02407-0.72%
Gaush Meditech Wins EU CE Mark for Corneal Confocal Microscope, Bolstering Global PushTip Ranks·Apr 10, 2026 at 11:40 AM02407-0.72%
Hong Kong Stock Movement Quick Report: XUNCE surged 15.36%, GAUSH MEDITECH fell 11.39%, market sentiment shows clear divergenceHK Stock Alerts·Mar 27, 2026 at 04:00 AM03317-3.16%02407-0.72%
GAUSH MEDITECH's annual net profit is RMB 96.19 million, an increase of 4.1%, with no dividend declaredAASTOCKS·Mar 26, 2026 at 09:08 PM02407-0.72%
Gaush Meditech’s Ophthalmic Diagnostic System Gains Approval in ChinaTip Ranks·Nov 10, 2025 at 01:42 PM02407-0.72%